Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer Cells
Top Cited Papers
- 1 December 2009
- Vol. 5 (23) , 2673-2677
- https://doi.org/10.1002/smll.200900621
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transportersProceedings of the National Academy of Sciences, 2008
- Drug Delivery with Carbon Nanotubes forIn vivoCancer TreatmentCancer Research, 2008
- Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular ImagingJournal of the American Chemical Society, 2008
- Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotidesNucleic Acids Research, 2008
- Determination of nanoparticle vehicle unpackaging by MR imaging of a T2 magnetic relaxation switchBiomaterials, 2008
- Unlocking the potential of the human genome with RNA interferenceNature, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Glutathione and related enzymes in multidrug resistanceEuropean Journal Of Cancer, 1996
- Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in cultureEuropean Journal Of Cancer, 1994